Tuberculosis Diagnostics Market Size, Share & Trends Report

Tuberculosis Diagnostics Market (2025 - 2030) Size, Share & Trends Analysis Report By Type (Detection Of Latent Infection, Phage Assay, Nucleic Acid Testing), By End-use (Diagnostic Laboratories, Hospitals & Clinic), By Region, And Segment Forecasts

Market Segmentation

Tuberculosis Diagnostics Type Outlook (Revenue, USD Million, 2018 - 2030)
- Detection of Latent Infection (Skin Test & IGRA)
- Phage Assay
- Detection of Drug Resistance (DST)
- Nucleic Acid Testing
- Radiographic Method
- Cytokine Detection Assay
- Others
Tuberculosis Diagnostics End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
Tuberculosis Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Tuberculosis Diagnostics Market, By Type
    - Detection of Latent Infection (Skin Test & IGRA)
    - Phage Assay
    - Detection of Drug Resistance (DST)
    - Nucleic Acid Testing
    - Radiographic Method
    - Cytokine Detection Assay
    - Others
  - North America Tuberculosis Diagnostics Market, By End Use
    - Diagnostic Laboratories
    - Hospitals & Clinics
    - Others
  - U.S.
    - U.S. Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - U.S. Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Canada
    - Canada Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Canada Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Mexico
    - Mexico Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Mexico Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
- Europe
  - Europe Tuberculosis Diagnostics Market, By Type
    - Detection of Latent Infection (Skin Test & IGRA)
    - Phage Assay
    - Detection of Drug Resistance (DST)
    - Nucleic Acid Testing
    - Radiographic Method
    - Cytokine Detection Assay
    - Others
  - Europe Tuberculosis Diagnostics Market, By End Use
    - Diagnostic Laboratories
    - Hospitals & Clinics
    - Others
  - UK
    - UK Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - UK Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Germany
    - Germany Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Germany Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - France
    - France Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - France Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Spain
    - Spain Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Spain Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Italy
    - Italy Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Italy Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Denmark
    - Denmark Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Denmark Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Sweden
    - Sweden Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Sweden Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Norway
    - Norway Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Norway Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
- Asia Pacific
  - Asia Pacific Tuberculosis Diagnostics Market, By Type
    - Detection of Latent Infection (Skin Test & IGRA)
    - Phage Assay
    - Detection of Drug Resistance (DST)
    - Nucleic Acid Testing
    - Radiographic Method
    - Cytokine Detection Assay
    - Others
  - Asia Pacific Tuberculosis Diagnostics Market, By End Use
    - Diagnostic Laboratories
    - Hospitals & Clinics
    - Others
  - Japan
    - Japan Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Japan Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - China
    - China Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - China Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - India
    - India Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - India Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Australia
    - Australia Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Australia Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - South Korea
    - South Korea Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - South Korea Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Thailand
    - Thailand Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Thailand Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
- Latin America
  - Latin America Pacific Tuberculosis Diagnostics Market, By Type
    - Detection of Latent Infection (Skin Test & IGRA)
    - Phage Assay
    - Detection of Drug Resistance (DST)
    - Nucleic Acid Testing
    - Radiographic Method
    - Cytokine Detection Assay
    - Others
  - Latin America Tuberculosis Diagnostics Market, By End Use
    - Diagnostic Laboratories
    - Hospitals & Clinics
    - Others
  - Brazil
    - Brazil Pacific Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Brazil Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Argentina
    - Argentina Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Argentina Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
- Middle East and Africa
  - Middle East and Africa Tuberculosis Diagnostics Market, By Type
    - Detection of Latent Infection (Skin Test & IGRA)
    - Phage Assay
    - Detection of Drug Resistance (DST)
    - Nucleic Acid Testing
    - Radiographic Method
    - Cytokine Detection Assay
    - Others
  - Middle East and Africa Tuberculosis Diagnostics Market, By End Use
    - Diagnostic Laboratories
    - Hospitals & Clinics
    - Others
  - South Africa
    - South Africa Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - South Africa Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Saudi Arabia
    - Saudi Arabia Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Saudi Arabia Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - UAE
    - UAE Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - UAE Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Kuwait
    - Kuwait Tuberculosis Diagnostics Market, By Type
      - Detection of Latent Infection (Skin Test & IGRA)
      - Phage Assay
      - Detection of Drug Resistance (DST)
      - Nucleic Acid Testing
      - Radiographic Method
      - Cytokine Detection Assay
      - Others
    - Kuwait Tuberculosis Diagnostics Market, By End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments